https://www.selleckchem.com/pr....oducts/telotristat-e
Very poor prognosis (viable birth rate 5%) was identified for women using oral medications or Clomid plus gonadotropins who were (1) age 35 with IM 49%, (2) age 35-37 with IM 56%, or (3) age ≥ 38, and (4) women age ≥ 38 using gonadotropins only with IM 60%. A clinical prediction model and nomogram was developed with an optimism-corrected c-statistic of 0.611. The present study highlights the impact of multiple clinical factors on IUI success, identifies criteria consistent with ver